glp-1 friendly America's biggest food companies are rethinking what's on grocery shelves and how they are marketing products. As weight-loss drugs curb the appetites of a growing number of consumers, brands are now Novo Nordisk Is Seeing Select Quantity:4 Bottles Triple Receptor Agonist

glp-1 friendly America's biggest food companies are rethinking what's on grocery shelves and how they are marketing products. As weight-loss drugs curb the appetites of a growing number of consumers, brands are now Novo Nordisk Is Seeing Select Quantity:4 Bottles Triple Receptor Agonist

Novo Nordisk Is Seeing Slowing Demand for GLP-1s Wegovy and Ozempic

doi: 10.2337/dc23-1135

Triple Receptor Agonist

Select Quantity:4 Bottles

Research showed that weight regain is common after discontinuing semaglutide (a common GLP-1 medication), with people regaining two-thirds of the weight they lost, and improvements in risk factors like blood pressure and HbA1c also reversed